What you should know about ketamine treatment from the world's top-ranked depression researcher
On October 6 we hosted a webinar with special guest Dr. Roger McIntyre, Braxia Scientific Chairman & CEO, and the world’s top-ranked depression researcher, to hear why researchers are calling ketamine a new breakthrough for depression management and mental wellness. (Braxia Scientific is KetaMD’s parent company.)
We also heard from Warren Gumpel, Co-Founder and CEO of KetaMD, on his own personal healing journey with ketamine, and why KetaMD was founded.
If you missed the event, we have you covered! Watch the full webinar, or read a transcript below including a special Q&A opportunity between attendees and the panel.
Make sure to join our waitlist for future webinars and events from the KetaMD team, and as always, we’re here to help.
Are you interested in learning more about KetaMD’s program?
Get started with us now to see if you are eligible for our at-home ketamine treatments. KetaMD is currently available in Florida with plans to expand nationally. If you are a Florida resident, click the button to get started now.
If you live outside of Florida, join our waitlist to be the first to know when KetaMD launches in your state.